Fujian Wanchen Biotechnology Co. Ltd (300972) — Financial Flexibility Index
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Financial Flexibility Index of 0.49x as of December 2025. Free cash flow of CN¥3.71 Billion (operating CF CN¥3.63 Billion minus capex CN¥77.44 Million) represents 0% of total liabilities (CN¥7.50 Billion). Also explore how fast is Fujian Wanchen Biotechnology Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fujian Wanchen Biotechnology Co. Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Fujian Wanchen Biotechnology Co. Ltd across 7 annual periods. Check 300972 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Fujian Wanchen Biotechnology Co. Ltd. For the full company profile including market capitalisation, see Fujian Wanchen Biotechnology Co. Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥3.71 Billion | CN¥3.63 Billion | CN¥7.50 Billion | ▲ +197.0% |
| 2024 | 0.17x | CN¥965.00 Million | CN¥848.35 Million | CN¥5.79 Billion | ▼ -56.7% |
| 2023 | 0.38x | CN¥1.24 Billion | CN¥1.02 Billion | CN¥3.23 Billion | ▼ -47.4% |
| 2022 | 0.73x | CN¥386.72 Million | CN¥70.38 Million | CN¥528.79 Million | ▲ +9.6% |
| 2021 | 0.67x | CN¥140.40 Million | CN¥98.82 Million | CN¥210.47 Million | ▼ -19.0% |
| 2020 | 0.82x | CN¥212.34 Million | CN¥156.24 Million | CN¥257.94 Million | ▲ +17.9% |
| 2019 | 0.70x | CN¥217.01 Million | CN¥177.28 Million | CN¥310.81 Million | — |